Our clinically proven and patented ExoSurge® technology uses injected and pulsated gases in tandem with intralesional drug injections to cause the permanent removal of fibrous tissue plaques associated with a Peyronie's Disease diagnosis.
Our years of research and development devoted to unlocking the epidemiology of Peyronie's plays a key role in our technology's success. We are science-driven and led by executives and medical advisors. Let us show you our plans to revolutionize the treatment of Peyronie’s disease.
